Prognostic determinants for long term outcome of low grade follicular lymphomas after cytoreductive chemotherapy and interferon alpha maintenance. Results of the German Low Grade Lymphoma Study Group (GLSG).

被引：0
|
作者：
Unterhalt, M [1 ]
Hermann, R [1 ]
Koch, P [1 ]
Trumper, L [1 ]
Bodenstein, H [1 ]
Dietzfelbinger, H [1 ]
Landys, K [1 ]
Reuss, M [1 ]
Vetter, H [1 ]
Maschmeyer, G [1 ]
Freund, M [1 ]
Neubauer, A [1 ]
Engert, A [1 ]
Stauder, R [1 ]
Herold, M [1 ]
Tiemann, M [1 ]
Parwaresch, R [1 ]
Stein, H [1 ]
Hiddemann, W [1 ]
机构：
[1] UNIV GOTTINGEN,DEPT HEMATOL ONCOL,D-37075 GOTTINGEN,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1743 / 1743
页数：1
相关论文
共 50 条
  • [21] Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -: results of a prospective randomized study of the German Low Grade Lymphoma Study Group
    Forstpointner, R
    Hänel, A
    Repp, R
    Hermann, S
    Metzner, B
    Pott, C
    Hartmann, F
    Rothmann, F
    Böck, HP
    Wandt, H
    Unterhalt, M
    Hiddemann, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (43) : 2253 - 2258
  • [22] LONG-TERM SURVIVAL AFTER HISTOLOGIC TRANSFORMATION OF LOW-GRADE FOLLICULAR LYMPHOMA
    YUEN, AR
    KAMEL, OW
    HALPERN, J
    HORNING, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1726 - 1733
  • [23] Prolonged Remission Duration with Interferon Maintenance After Rituximab-Containing Induction in First-Line Advanced Stage Lymphoplasmacytic Lymphoma - a Retrospective Analysis of the German Low-Grade Lymphoma Study Group (GLSG)
    Hoster, Eva
    Unterhalt, Michael
    Metzner, Bernd
    Pfreundschuh, Michael
    Staib, Peter
    Jacobs, Georg
    Lindemann, Hans Walter
    Ludwig, Wolf-Dieter
    Steinmetz, H. Tilman
    Truemper, Lorenz
    Wandt, Hannes
    Buske, Christian
    Dreyling, Martin H.
    Hiddemann, Wolfgang
    BLOOD, 2011, 118 (21) : 712 - 712
  • [24] Interferon maintenance prolongs remission duration after Rituximab-containing induction in first-line advanced stage lymphoplasmacytic lymphoma - a retrospective analysis of the German Low-Grade Lymphoma Study Group (GLSG)
    Hoster, E.
    Unterhalt, M.
    Metzner, B.
    Pfreundschuh, M.
    Staib, P.
    Dreyling, M.
    Hiddemann, W.
    ONKOLOGIE, 2011, 34 : 98 - 98
  • [25] Combined immuno-chemotherapy (R-CHOP) significantly improves time to treatment failure in first line therapy of follicular lymphoma -: Results of a prospective Randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Hiddemann, W
    Dreyling, MH
    Forstpointner, R
    Kneba, M
    Woermann, B
    Lengfelder, E
    Schmits, R
    Reiser, M
    Metzner, B
    Schmitz, N
    Truemper, L
    Eimermacher, H
    Parwaresch, R
    BLOOD, 2003, 102 (11) : 104A - 104A
  • [26] Rituximab in Combination with CHOP in Patients with Follicular Lymphoma: Analysis of Treatment Outcome of 552 Patients Treated in a Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG) after a Follow up of 58 Months.
    Buske, Christian
    Hoster, Eva
    Dreyling, Martin
    Forstpointner, Roswitha
    Kneba, Michael
    Schmitz, Norbert
    Schmits, Rudolf
    Metzner, Bernd
    Reiser, Marcel
    Lengfelder, Eva
    Woermann, Bernhard J.
    Harder, Harriet
    Hegewisch-Becker, Susanna
    Berdel, Wolfgang E.
    Hess, Georg
    Eimermacher, Hartmut
    Aldaoud, Ali
    Planker, Manfred
    Unterhalt, Michael
    Hiddemann, Wolfgang
    BLOOD, 2008, 112 (11) : 901 - 901
  • [27] Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma-Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group (GLSG)
    Jurinovic, Vindi
    Metzner, Bernd
    Pfreundschuh, Michael
    Schmitz, Norbert
    Wandt, Hannes
    Peschel, Christian
    Dreyling, Martin
    Hiddemann, Wolfgang
    Hoster, Eva
    Unterhalt, Michael
    Weigert, Oliver
    BLOOD, 2016, 128 (22)
  • [28] Rituximab maintenance improves progression-free and overall survival rates after combined immuno-chemotherapy (R-FCM) in patients with relapsed follicular and mantle cell lymphoma:: Final results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Dreyling, M.
    Forstpointner, R.
    Gramatzki, M.
    Boeck, H.
    Haenel, M.
    Seymour, J.
    Planker, M.
    Duehrsen, U.
    Wilms, K.
    Unterhalt, M.
    Hiddemann, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 422S - 422S
  • [29] Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))
    Herfarth, Klaus
    Engelhard, Marianne
    Borchmann, Peter
    Hohloch, Karin
    Budach, Volker
    Viardot, Andreas
    Witzens-Harig, Mathias
    Eich, Hans
    Hiddemann, Wolfgang
    Dreyling, Martin
    BLOOD, 2012, 120 (21)
  • [30] MCP (Mitoxantrone/Chlorambucil/Prednisolone) chemotherapy impairs the subsequent collection of stem cells in comparison to CHOP induction in patients with indolent lymphomas -: Results of a prospective randomized trial of the German low grade lymphoma study group (GLSG).
    Nickenig, C
    Dreyling, M
    Hoster, E
    Pfreundschuh, M
    Truemper, L
    Reiser, M
    Wandt, H
    Unterhalt, M
    Hiddemann, W
    BLOOD, 2005, 106 (11) : 931A - 931A
12345